% Options for packages loaded elsewhere
\PassOptionsToPackage{unicode}{hyperref}
\PassOptionsToPackage{hyphens}{url}
%
\documentclass[
]{article}
\usepackage{lmodern}
\usepackage{amssymb,amsmath}
\usepackage{ifxetex,ifluatex}
\ifnum 0\ifxetex 1\fi\ifluatex 1\fi=0 % if pdftex
  \usepackage[T1]{fontenc}
  \usepackage[utf8]{inputenc}
  \usepackage{textcomp} % provide euro and other symbols
\else % if luatex or xetex
  \usepackage{unicode-math}
  \defaultfontfeatures{Scale=MatchLowercase}
  \defaultfontfeatures[\rmfamily]{Ligatures=TeX,Scale=1}
\fi
% Use upquote if available, for straight quotes in verbatim environments
\IfFileExists{upquote.sty}{\usepackage{upquote}}{}
\IfFileExists{microtype.sty}{% use microtype if available
  \usepackage[]{microtype}
  \UseMicrotypeSet[protrusion]{basicmath} % disable protrusion for tt fonts
}{}
\makeatletter
\@ifundefined{KOMAClassName}{% if non-KOMA class
  \IfFileExists{parskip.sty}{%
    \usepackage{parskip}
  }{% else
    \setlength{\parindent}{0pt}
    \setlength{\parskip}{6pt plus 2pt minus 1pt}}
}{% if KOMA class
  \KOMAoptions{parskip=half}}
\makeatother
\usepackage{xcolor}
\IfFileExists{xurl.sty}{\usepackage{xurl}}{} % add URL line breaks if available
\IfFileExists{bookmark.sty}{\usepackage{bookmark}}{\usepackage{hyperref}}
\hypersetup{
  pdftitle={Analysis},
  pdfauthor={Huang LiChuang of Wie-Biotech},
  hidelinks,
  pdfcreator={LaTeX via pandoc}}
\urlstyle{same} % disable monospaced font for URLs
\usepackage[margin=1in]{geometry}
\usepackage{longtable,booktabs}
% Correct order of tables after \paragraph or \subparagraph
\usepackage{etoolbox}
\makeatletter
\patchcmd\longtable{\par}{\if@noskipsec\mbox{}\fi\par}{}{}
\makeatother
% Allow footnotes in longtable head/foot
\IfFileExists{footnotehyper.sty}{\usepackage{footnotehyper}}{\usepackage{footnote}}
\makesavenoteenv{longtable}
\usepackage{graphicx}
\makeatletter
\def\maxwidth{\ifdim\Gin@nat@width>\linewidth\linewidth\else\Gin@nat@width\fi}
\def\maxheight{\ifdim\Gin@nat@height>\textheight\textheight\else\Gin@nat@height\fi}
\makeatother
% Scale images if necessary, so that they will not overflow the page
% margins by default, and it is still possible to overwrite the defaults
% using explicit options in \includegraphics[width, height, ...]{}
\setkeys{Gin}{width=\maxwidth,height=\maxheight,keepaspectratio}
% Set default figure placement to htbp
\makeatletter
\def\fps@figure{htbp}
\makeatother
\setlength{\emergencystretch}{3em} % prevent overfull lines
\providecommand{\tightlist}{%
  \setlength{\itemsep}{0pt}\setlength{\parskip}{0pt}}
\setcounter{secnumdepth}{5}
\usepackage{caption} \captionsetup{font={footnotesize},width=6in} \renewcommand{\dblfloatpagefraction}{.9} \makeatletter \renewenvironment{figure} {\def\@captype{figure}} \makeatother \definecolor{shadecolor}{RGB}{242,242,242} \usepackage{xeCJK} \usepackage{setspace} \setstretch{1.3} \usepackage{tcolorbox}
\newlength{\cslhangindent}
\setlength{\cslhangindent}{1.5em}
\newenvironment{cslreferences}%
  {}%
  {\par}

\title{Analysis}
\author{Huang LiChuang of Wie-Biotech}
\date{}

\begin{document}
\maketitle

{
\setcounter{tocdepth}{4}
\tableofcontents
}
\listoffigures

\listoftables

\hypertarget{ux9898ux76ee}{%
\section{题目}\label{ux9898ux76ee}}

\hypertarget{abstract}{%
\section{摘要}\label{abstract}}

\hypertarget{introduction}{%
\section{前言}\label{introduction}}

CKD 与患癌症风险之间的联系尚未明确。尽管多项研究观察到需要透析或肾移植的 ESRD 患者患癌症的风险较高，但不太严重的肾脏疾病是否与癌症相关仍知之甚少\textsuperscript{\protect\hyperlink{ref-OnconephrologyRosner2021}{1}--\protect\hyperlink{ref-CancerRiskAndKitchl2022}{3}}。

肾癌流行病学\textsuperscript{\protect\hyperlink{ref-EpidemiologyOfBukavi2022}{4}}

CKD 和肾癌\textsuperscript{\protect\hyperlink{ref-RenalCellCancSaly2021}{5}}

Cancer Risk and Mortality in Patients With Kidney Disease: Cancer risk was increased in mild to moderate CKD and among transplant recipients\textsuperscript{\protect\hyperlink{ref-CancerRiskAndKitchl2022}{3}}

\hypertarget{route}{%
\section{研究设计流程图}\label{route}}

TCGA 突变数据
TCGA 转录数据
基因共表达
免疫浸润水平
生存分析
timeROC
单细胞数据验证

多种慢性肾病的 FC
癌症的 FC
用基因集的 FC 来关联分析 (需要多个 GEO 数据集)

\begin{itemize}
\tightlist
\item
  Kidney status markers
\item
  cancer markers
\item
  micro-envir\ldots{}
\item
  ferroptosis
\item
  \ldots{}
\end{itemize}

\hypertarget{methods}{%
\section{材料和方法}\label{methods}}

\hypertarget{results}{%
\section{分析结果}\label{results}}

\hypertarget{dis}{%
\section{结论}\label{dis}}

\hypertarget{ux9644ux5206ux6790ux6d41ux7a0b}{%
\section{附：分析流程}\label{ux9644ux5206ux6790ux6d41ux7a0b}}

\hypertarget{ux80beux764c-geo}{%
\subsection{肾癌 (GEO)}\label{ux80beux764c-geo}}

\hypertarget{gse171306}{%
\subsubsection{GSE171306}\label{gse171306}}

\begin{verbatim}
- Single-cell RNA sequencing (scRNA-seq) was performed on bilateral clear
  cell RCC (ccRCC). Primary kidney samples from 3 patients were used for
  single cell RNA sequencing by 10X Genomics
\end{verbatim}

\hypertarget{ux7ec6ux80deux805aux7c7bux548cux6ce8ux91ca}{%
\paragraph{细胞聚类和注释}\label{ux7ec6ux80deux805aux7c7bux548cux6ce8ux91ca}}

\hypertarget{ux764cux7ec6ux80deux8bc6ux522b}{%
\paragraph{癌细胞识别}\label{ux764cux7ec6ux80deux8bc6ux522b}}

\hypertarget{ux764cux7ec6ux80deux62dfux65f6ux5206ux6790}{%
\paragraph{癌细胞拟时分析}\label{ux764cux7ec6ux80deux62dfux65f6ux5206ux6790}}

\hypertarget{ux80beux764c-tcga-kirc}{%
\subsection{肾癌 (TCGA-KIRC)}\label{ux80beux764c-tcga-kirc}}

\hypertarget{tcga-ux6570ux636e}{%
\subsubsection{TCGA 数据}\label{tcga-ux6570ux636e}}

\hypertarget{ux8840ux7ba1ux6027ux75beux60a3}{%
\subsection{血管性疾患}\label{ux8840ux7ba1ux6027ux75beux60a3}}

\hypertarget{ux9ad8ux8840ux538bux6027ux80beux708ehypertensive-nephropathy}{%
\subsubsection{高血压性肾炎（hypertensive nephropathy）}\label{ux9ad8ux8840ux538bux6027ux80beux708ehypertensive-nephropathy}}

\begin{itemize}
\tightlist
\item
  GSE210898: Single-cell RNA transcriptomics of hypertensive nephropathy patients
\end{itemize}

\hypertarget{ux7ec6ux80deux805aux7c7bux548cux6ce8ux91ca-1}{%
\paragraph{细胞聚类和注释}\label{ux7ec6ux80deux805aux7c7bux548cux6ce8ux91ca-1}}

\hypertarget{ux539fux53d1ux6027ux80beux5c0fux7403ux6027ux75beux60a3}{%
\subsection{（原发性）肾小球性疾患}\label{ux539fux53d1ux6027ux80beux5c0fux7403ux6027ux75beux60a3}}

\hypertarget{iga-ux80beux75c5-iga-nephropathy}{%
\subsubsection{IgA 肾病 (IgA Nephropathy)}\label{iga-ux80beux75c5-iga-nephropathy}}

\begin{itemize}
\tightlist
\item
  GSE171314, scRNA-seq
\item
  GSE145652, RNA-seq
\item
  GSE175759, RNA-seq
\end{itemize}

\hypertarget{ux819cux6027ux80beux75c5-idiopathic-membranous-nephropathy}{%
\subsubsection{膜性肾病 (idiopathic membranous nephropathy)}\label{ux819cux6027ux80beux75c5-idiopathic-membranous-nephropathy}}

\begin{itemize}
\tightlist
\item
  GSE241302, scRNA
\item
  GSE216841, RNA-seq
\item
  GSE175759, RNA-seq
\end{itemize}

\hypertarget{ux5faeux5c0fux75c5ux53d8ux80beux75c5-minimal-change-disease}{%
\subsubsection{微小病变肾病 (Minimal change disease)}\label{ux5faeux5c0fux75c5ux53d8ux80beux75c5-minimal-change-disease}}

\begin{itemize}
\tightlist
\item
  GSE176465, scRNA (only but not fit)
\item
  GSE216841, RNA-seq
\item
  GSE175759, RNA-seq
\end{itemize}

\hypertarget{ux7ee7ux53d1ux6027ux80beux5c0fux7403ux6027ux75beux60a3}{%
\subsection{（继发性）肾小球性疾患}\label{ux7ee7ux53d1ux6027ux80beux5c0fux7403ux6027ux75beux60a3}}

\hypertarget{ux7cd6ux5c3fux75c5ux80beux75c5-diabetic-kidney-disease}{%
\subsubsection{糖尿病肾病 (Diabetic kidney disease)}\label{ux7cd6ux5c3fux75c5ux80beux75c5-diabetic-kidney-disease}}

\begin{itemize}
\tightlist
\item
  GSE204880, scRNA
\item
  GSE175759, RNA-seq
\item
  GSE199838, RNA-seq
\item
  GSE217709, RNA-seq
\end{itemize}

\hypertarget{ux72fcux75aeux6027ux80beux708e-lupus-nephritis}{%
\subsubsection{狼疮性肾炎 (lupus nephritis)}\label{ux72fcux75aeux6027ux80beux708e-lupus-nephritis}}

\begin{itemize}
\tightlist
\item
  no scRNA
\item
  GSE175759, RNA-seq
\item
  GSE157293, RNA-seq
\end{itemize}

\hypertarget{bibliography}{%
\section*{Reference}\label{bibliography}}
\addcontentsline{toc}{section}{Reference}

\hypertarget{refs}{}
\begin{cslreferences}
\leavevmode\hypertarget{ref-OnconephrologyRosner2021}{}%
1. Rosner, M. H., Jhaveri, K. D., McMahon, B. A. \& Perazella, M. A. Onconephrology: The intersections between the kidney and cancer. \emph{CA: a cancer journal for clinicians} \textbf{71}, 47--77 (2021).

\leavevmode\hypertarget{ref-CkdAndTheRisLowran2014}{}%
2. Lowrance, W. T., Ordoñez, J., Udaltsova, N., Russo, P. \& Go, A. S. CKD and the risk of incident cancer. \emph{Journal of the American Society of Nephrology} \textbf{25}, (2014).

\leavevmode\hypertarget{ref-CancerRiskAndKitchl2022}{}%
3. Kitchlu, A. \emph{et al.} Cancer risk and mortality in patients with kidney disease: A population-based cohort study. \emph{American journal of kidney diseases : the official journal of the National Kidney Foundation} \textbf{80}, 436--448.e1 (2022).

\leavevmode\hypertarget{ref-EpidemiologyOfBukavi2022}{}%
4. Bukavina, L. \emph{et al.} Epidemiology of renal cell carcinoma: 2022 update. \emph{European Urology} \textbf{82}, (2022).

\leavevmode\hypertarget{ref-RenalCellCancSaly2021}{}%
5. Saly, D. L., Eswarappa, M. S., Street, S. E. \& Deshpande, P. Renal cell cancer and chronic kidney disease. \emph{Advances in chronic kidney disease} \textbf{28}, 460--468.e1 (2021).
\end{cslreferences}

\end{document}
